Back to Search
CH HASSAN ALI, M.D
M.D
Neurology Physician
NPI: 1194382887IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
MD26861(ME)
CMS Specialties
PrimaryNEUROLOGY
Education
OTHER
Class of 2018
Research & Publications (20)
Implantation, clinical pregnancy and miscarriage rates after introduction of ultrasound-guided embryo transfer.
PMID 18616896·Reprod Biomed Online·2008
8-other
CA 19-9 and survival in advanced and unresectable pancreatic adenocarcinoma and cholangiocarcinoma.
PMID 19089662·J Gastrointest Cancer·2007
8-other
Omental and peritoneal secondary trophoblastic implantation - an unusual complication after IVF.
PMID 16792857·Reprod Biomed Online·2006
8-other
Seroepidemiology of Toxoplasma gondii in dogs in Trinidad and Tobago.
PMID 12719132·Vet Parasitol·2003
7-preclinical
Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact.
PMID 19574439·Brain·2009
7-preclinical
Newborn- and adult-derived brain microvascular endothelial cells show age-related differences in phenotype and glutamate-evoked protease release.
PMID 19367295·J Cereb Blood Flow Metab·2009
7-preclinical
Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic.
PMID 18963068·Trends Neurosci·2009
6-review
Anti-Mullerian-hormone-dependent regulation of the brain serine-protease inhibitor neuroserpin.
PMID 18796535·J Cell Sci·2008
7-preclinical
MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism.
PMID 18828900·BMC Cancer·2008
8-other
Toward safer thrombolytic agents in stroke: molecular requirements for NMDA receptor-mediated neurotoxicity.
PMID 18334994·J Cereb Blood Flow Metab·2008
7-preclinical
Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory.
PMID 17244650·J Cell Sci·2007
7-preclinical
Recombinant Desmodus rotundus salivary plasminogen activator crosses the blood-brain barrier through a low-density lipoprotein receptor-related protein-dependent mechanism without exerting neurotoxic effects.
PMID 17325305·Stroke·2007
4-observational
Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation.
PMID 17229577·Mol Cell Neurosci·2007
7-preclinical
Neurobehavioral and immunological consequences of prenatal immune activation in rats. Influence of antipsychotics.
PMID 17180123·Neuropsychopharmacology·2007
7-preclinical
[Analysis of antibiotics as a curative measure in four hospital units].
PMID 17263202·Tunis Med·2006
8-other
Tissue-type plasminogen activator rescues neurones from serum deprivation-induced apoptosis through a mechanism independent of its proteolytic activity.
PMID 16800849·J Neurochem·2006
4-observational
The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo.
PMID 16209928·Mol Cell Neurosci·2005
7-preclinical
NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production.
PMID 16221845·J Neurosci·2005
4-observational
Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis.
PMID 15851587·Circulation·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 905 UNION ST STE 9
BANGOR, ME 04401 - Phone
- (301) 326-8421
Quick Facts
- NPI
- 1194382887
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 8
- Publications
- 20
Are you this provider?
Claim Your Profile